It does not really take an expensive scan to diagnose Alzheimer’s disease. Although, recent research’s suggests, PET scans might cause some changes in the treatment. The discoveries, announced Wednesday, check a first look at a gigantic report under approach to help decide whether Medicare should begin paying for particular PET scans that discover a sign of Alzheimer’s which is a sticky plaque called amyloid. Alzheimer’s disease is the most common form of dementia and to diagnose it, classic symptoms and memory tests are often enough. There could also be unusual symptoms which could spot another form of dementia to which there are no cures but could require different type of care for symptoms.
About New Research’s
It is difficult to tell if mild memory loss might be a sign of early Alzheimer’s, depression, or an age-related decline. Dr. Gil Rabinovici, of the University of California, San Francisco, leading the new research said that they are not yet accurate enough with the results of the research and that the patients come to know that there is something wrong with them as it is not just normal ageing. He also stated that the doctors hesitate to make diagnosis without clear tests.
Until some years ago, amyloid build-up could only be detected during autopsies. However, it is unclear how best amyloid detecting scans, which are too costly, can be used. Alzheimer’s can be ruled out if there’s less amyloid. But healthy seniors can also show amyloid, and outside of a few research studies, Medicare would not pay for new scans. One of those research studies is the IDEAS study. In addition to people who qualify for the IDEAS research study, the Alzheimer’s Association and Society of Nuclear Medicine and Molecular Imaging said that patients having dementia who are younger than the age of 65, may also be applicants for a PET scan, the scans should not be used for people who do not have symptoms or people who worry that they are at risk, and they are not for the people whose disease can be diagnosed by standard methods, or to check the severity of the disease.